Condition
Catecholaminergic Polymorphic Ventricular Tachycardia clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Catecholaminergic Polymorphic Ventricular Tachycardia clinical trials that are recruiting, at sites in 9 countries (most in Canada (2), United States (2), Germany (1)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 9Countries
Newest Catecholaminergic Polymorphic Ventricular Tachycardia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AGP100 to reduce exercise- and stress-triggered abnormal heart rhythms in people with CPVT | Phase 2 | Oslo | Recruiting | Dec 4, 2025 |
| SGT-501 gene therapy for RYR2-related CPVT | Phase 1 | Boston, Massachusetts and 4 other locations | Recruiting | Aug 29, 2025 |
| Phase 2 test of CRD-4730 for Catecholaminergic Polymorphic Ventricular Tachycardia | Phase 2 | San Francisco, California and 11 other locations | Recruiting | Oct 26, 2024 |
| Registry for hereditary cardiovascular diseases in Brazil | — | Rio Branco, Acre and 26 other locations | Recruiting | Aug 9, 2024 |
| Long-term outcomes for patients with cardiac arrhythmias | — | Hamburg | Recruiting | Aug 30, 2022 |
All recruiting trials (5)
-
AGP100 to reduce exercise- and stress-triggered abnormal heart rhythms in people with CPVT
This trial will test whether AGP100 helps adults with CPVT keep a normal heart rhythm during exercise while checking that the medicine is safe and tolerable.
-
SGT-501 gene therapy for RYR2-related CPVT
This will test whether a single intravenous dose of SGT-501 is safe and tolerable for people with RYR2-positive CPVT, including adults and children.
-
Phase 2 test of CRD-4730 for Catecholaminergic Polymorphic Ventricular Tachycardia
This trial will test whether two doses of the experimental drug CRD-4730 are safe and affect exercise-induced dangerous heart rhythms in adults with CPVT.
-
Registry for hereditary cardiovascular diseases in Brazil
This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.
-
Long-term outcomes for patients with cardiac arrhythmias
This study looks at how well treatments for heart rhythm problems work over time and what factors might affect their success for patients with conditions like atrial fibrillation and ventricular tachycardia.
Related topics
Quick answers
How many Catecholaminergic Polymorphic Ventricular Tachycardia clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in Canada (2 trials), United States (2 trials), Germany (1 trial), Norway (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.